Modular Medical (MODD) Non-Current Deferred Tax Liability (2022 - 2023)
Modular Medical's (MODD) quarterly Non-Current Deferred Tax Liability came in at $1.7 million in Q1 2023, up 67.81% on a YoY basis from $988000.0 in Q1 2022, and up 67.81% quarter-over-quarter from $988000.0 in Q1 2022.
Powered by 
Analysis
Modular Medical (MODD) Non-Current Deferred Tax Liability (2022 - 2023) Analysis & Trends
Modular Medical (MODD) has reported Non-Current Deferred Tax Liability for 2 consecutive years, with $1.7 million the latest figure, recorded in Q1 2023.
- For the quarter ending Q1 2023, Non-Current Deferred Tax Liability rose 67.81% year-over-year to $1.7 million; the trailing twelve-month figure through Mar 2023 stood at $1.7 million (up 67.81% YoY), and the FY2023 full-year result was $1.7 million, up 67.81% from the prior year.
- Non-Current Deferred Tax Liability grew to $1.7 million in Q1 2023 per MODD's latest filing, from $988000.0 in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $1.7 million in Q1 2023 and bottomed at $988000.0 in Q1 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Modular Medical | 15.54 Mn | 11.62 Mn | - |